FT Pharma Pricing and Value Summit

FT Pharma Pricing and Value Summit is organized by Financial Times (FT) Live and will be held on Sep 26, 2019 at Stewart Hotel, New York City, New York, United States of America.

Who Will Be There?
FT Live has a reputation for delivering very senior, board-level audiences to attend a wide range of world-class thought-leadership events across the globe for nearly 40 years.
The FT Pharma Pricing and Value Summit will be attended by:
• Pharmaceutical companies
• Pharmacy benefit managers
• Medical device manufacturers
• Healthcare providers and insurers
• Patient representatives and NGOs

Description:
The pharmaceutical pricing and market access landscape is being transformed by a host of factors. Value-based pricing is making the transition from concept to reality but more clarity is needed on what it means and how it works for different stakeholders. Revolutionary therapies with innovative pricing models are entering the market but at the same time decision-makers at pharma companies are being asked to defend pricing strategies for established products. Meanwhile, much of the US government's blueprint to lower drug prices is still in the works and yet to be enacted.

Under the theme 'Entering a New Era for Market Access', this year's Summit will explore the future of drug pricing from a balanced perspective. The rebate system, new powers for Medicare Part D, global factors that could affect the pricing and market access landscape in the US, as well as the effects of public pressure and President Trump's Blueprint to Lower Drug Prices. will all be examined under the chairmanship of Sarah Neville, Global Pharmaceuticals Editor of the Financial Times.

Speakers: Sarah Emond, Executive Vice President and Chief Operating Officer Institute, for Clinical and Economic Review (ICER), Robert Dubois, Chief Science Officer and Executive Vice President, National Pharmaceutical Council (NPC), Rick R. Suarez, Senior Vice President, US Market Access, AstraZeneca, Tony Barrueta, Senior Vice President of Government Relations, Kaiser Foundation Health Plan and Hospitals, Kathleen Tregoning, Executive Vice President, External Affairs Sanofi, Christoph Glaetzer, Vice President, Global Market Access Janssen, Chris Leibman, Senior Vice President, Value and Access Biogen

Time: 09:00 - 16:20